Clinical trials: Evaluation of QTc Interval
Evaluation of QTc Interval
QT Interval Effects Study of Oral FXS5626 Tablets
The purpose of this study is to evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc interval of a single oral dose of FXS5626 in healthy subjects.
- Trial name
- NCT07695779
- Testing
- FXS5626 tablet
- Where
- China
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.